Healthcare stocks are narrowly lower, with the NYSE Healthcare
Sector Index slipping about 0.1% and shares of healthcare companies
in the S&P 500 declining about 0.1% as a group.
In company news, Health Management Associates (
) is ahead nearly 6% at $13.27 a share in early afternoon trade
after saying its board is recommending that shareholders vote in
favor of a $7.6-billion buyout proposal from Community Health
), accepting either $10.50 in cash or 0.06942 of a CYH share as
well as a Contingent Value Right - worth up to $1 per share - in
exchange for each share they now own.
CYH was also higher in early trade, rising 2.5% to $43.38 a
HMA also reported a Q3 loss of $0.01 per share, reversing a
$0.22-per-share profit during the same quarter last year and
missing the Capital IQ consensus call looking for a $0.15 per share
Revenue, before provisions for doubtful accounts, rose 0.6% year
over year to $1.67 billion, matching analyst expectations.
Looking forward, the owner and manager of hospitals and
ambulatory surgery centers said it is now expecting FY13 net
revenue, before provisions for doubtful accounts, of between $6.84
billion to $6.86 billion, trailing estimates by at least $40
million, or less than 0.6%. EPS is projected in a range of $0.48 to
$0.50, also lagging the analyst consensus by at least $0.10 per
In other sector news,
(+) SVA, (+5.3%) Chinese drug-maker earns $0.04 per share in Q3,
reversing year-ago net loss of $0.05 per share and topping analyst
estimates expecting a $0.02 per share loss. Sales increase 54.5%
year over year to $22.1 mln, topping consensus view by $4.08
(-) CHTP, (-6.9%) Prices offering of 6.66 mln shares at $3 each,
a 9% discount to Tuesday's closing price. Deal generated $20 mln in
gross proceeds, which will be used to seek regulatory approvals and
fund commercialization of its droxidopa drug candidate.
Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.